Cargando…
Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion
Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case,...
Autores principales: | Nagpal, Manish, Mehta, Vikram, Nagpal, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350047/ https://www.ncbi.nlm.nih.gov/pubmed/22606470 http://dx.doi.org/10.1155/2011/679751 |
Ejemplares similares
-
Full-thickness macular hole formation following antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion
por: Mitra, Srijita, et al.
Publicado: (2021) -
Hemicentral retinal artery occlusion in young adults
por: Chopdar, Amresh
Publicado: (2013) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008) -
En-face optical coherence tomography angiography of neovascularization elsewhere in hemicentral retinal vein occlusion
por: Sogawa, Kenji, et al.
Publicado: (2015) -
The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska, Biljana, et al.
Publicado: (2017)